Skip to main content

Dharmacon and UMMS Join for RNAi Obesity and Diabetes Studies

NEW YORK, Jan. 8 (GenomeWeb News) - Dharmacon and the University of Massachusetts Medical School said today they will collaborate in studies of obesity and diabetes using RNA interference.


Dharmacon, based in Lafayette, Colo., will provide UMMS researchers, directed by Michael Czech, with siRNA reagents for the studies. The scientists plan to assess several thousand gene targets over a three-year period.


In return, Dharmacon will obtain access to the study data to assess the effectiveness of its siRNA technologies.


The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.